Abstract：
This review article will summarize the vaccines and monoclonal antibodies currently under evaluation for the prevention of RSV disease in older infants, toddlers and young children. We will review the rationale for passive protection during the first months of life, and the role of active immunization afterwards, either with live attenuated, protein-based or mRNA vaccines.
摘要：
本文将总结目前正在评估的疫苗和单克隆抗体，用于预防年龄较大的婴儿RSV疾病。幼儿和幼儿。我们将在生命的最初几个月中回顾被动保护的基本原理，以及之后主动免疫的作用，无论是活减毒，基于蛋白质或mRNA的疫苗。
